Emergent BioSolutions Inc. (EBS) Revenue History
Emergent BioSolutions Inc. (EBS) annual revenue history. Get revenue data in Excel with MarketXLS.
Revenue Data
| Period | Revenue (USD) |
|---|---|
| 2016-12-31 | $488.78M |
| 2017-12-31 | $560.90M |
| 2018-12-31 | $782.40M |
| 2019-12-31 | $1.11B |
| 2020-12-31 | $1.27B |
| 2021-12-31 | $1.49B |
| 2022-12-31 | $1.08B |
| 2023-12-31 | $1.05B |
| 2024-12-31 | $1.04B |
| 2025-12-31 | $742.90M |
How EBS compares with sector peers
| Symbol | Company | Revenue (latest fiscal year) |
|---|---|---|
| MYGN | Myriad Genetics Inc. | $824.50M |
| USPH | U.S. Physical Therapy Inc. | $780.99M |
| NEO | NeoGenomics Inc. | $727.33M |
| AMPH | Amphastar Pharmaceuticals Inc. | $719.89M |
| RARE | Ultragenyx Pharmaceutical Inc. | $673.00M |
These are five companies in the same sector as EBS with a comparable annual revenue. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Emergent BioSolutions Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Revenue("EBS", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | EBS | $5.08 | +5.39% | 1.42M |
| 3 | ||||
| 4 | ||||
| 5 |